Publications

Avelumab First-Line (1L) Maintenance for Advanced Urothelial Carcinoma (Uc): Long-Term Follow-Up Results from the Javelin Bladder 100 Trial.

AuthID
P-00W-E77

Author(s)

Powles, T

Park, SH

Voog, E

Caserta, C

Perez-Valderrama, B

Gurney, H

Loriot, Y

Sridhar, SS

Tsuchiya, N

Sternberg, CN

Bellmunt, J

Aragon-Ching, JB

Petrylak, DP

Blake-Haskins, A

Laliberte, RJ

Wang, J

Costa, NM

Grivas, P

Document Type

Abstract

Year published

2022

Published

in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X

Volume: 40, Issue: 6

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1200/jco.2022.40.6_suppl.487

Wos: WOS:000771008900494

Source Identifiers

ISSN: 0732-183X

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Avelumab First-Line (1L) Maintenance for Advanced Urothelial Carcinoma (Uc): Long-Term Follow-Up Results from the Javelin Bladder 100 Trial.

Useful Links

Get Help

Federated Authentication (Click on the image)

Avelumab First-Line (1L) Maintenance for Advanced Urothelial Carcinoma (Uc): Long-Term Follow-Up Results from the Javelin Bladder 100 Trial.

Useful Links

Get Help